Alzamend Neuro Inc (ALZN) Stock Price, Quote, News & History

ALZNNASDAQ
$1.72
0.021.18%
At close: Sep 10, 5:00 PM EST
$1.68
-0.02-1.18%
Pre-Market: 4:00 AM EST
Earnings: Q1 2027 Earnings were released on Thu Sep 10th, after the market close

Alzamend Neuro (ALZN) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.84M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
8.81M
Free Cash Flow (TTM)
-6.84M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.97M

Analyst Trends and Forecast

1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$805.32K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.45
Earnings Yield % (TTM)
-116.67%
Earnings Yield % (FWD)
-70.69%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.20

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$7.59M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$1.72
Volume / Avg.
0 / 162.64K
Day Range
- - -
52 Wk Range
0.84 - 2.68
Market Cap
$8.11M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
65
Short Interest
3.36%
Days to Cover
1.04

About

Sector
Health Care
Industry
Biotechnology
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic dru...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alzamend Neuro (ALZN) stock?

A

You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alzamend Neuro (ALZN) competitors?

Q

What is the forecast, or price target, for Alzamend Neuro (ALZN) stock?

A

Alzamend Neuro has a consensus price target of $26.00.

Q

What is the current price for Alzamend Neuro (ALZN)?

A

The stock price for Alzamend Neuro (NASDAQ: ALZN) is $1.68 last updated September 11, 2026 at 7:00 AM EDT.

Q

Does Alzamend Neuro (ALZN) pay a dividend?

A

There are no upcoming dividends for Alzamend Neuro.

Q

When is Alzamend Neuro (NASDAQ:ALZN) reporting earnings?

A

Alzamend Neuro does not have any upcoming earnings scheduled.

Q

Is Alzamend Neuro (ALZN) going to split?

A

There is no upcoming split for Alzamend Neuro.

Q

What sector and industry does Alzamend Neuro (ALZN) operate in?

A

Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.